Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan vs Propranolol for Migraine Prevention
NCT00884663Phase 3Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Apr 2009
- Primary completion
- Mar 2012
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of candesartan in migraine, sponsored by Norwegian University of Science and Technology. Started Apr 2009; status: completed.
02
Drugs
candesartan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00884663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00884663.